HK196796A - Use of aromatic diamines for the treatment of angina pectoris and diamines therefor - Google Patents

Use of aromatic diamines for the treatment of angina pectoris and diamines therefor

Info

Publication number
HK196796A
HK196796A HK196796A HK196796A HK196796A HK 196796 A HK196796 A HK 196796A HK 196796 A HK196796 A HK 196796A HK 196796 A HK196796 A HK 196796A HK 196796 A HK196796 A HK 196796A
Authority
HK
Hong Kong
Prior art keywords
diamines
therefor
treatment
angina pectoris
aromatic
Prior art date
Application number
HK196796A
Other languages
English (en)
Inventor
Harald Maschler
Original Assignee
Beecham Wuelfing Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Wuelfing Gmbh & Co Kg filed Critical Beecham Wuelfing Gmbh & Co Kg
Publication of HK196796A publication Critical patent/HK196796A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK196796A 1986-02-15 1996-10-24 Use of aromatic diamines for the treatment of angina pectoris and diamines therefor HK196796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868603765A GB8603765D0 (en) 1986-02-15 1986-02-15 Compounds

Publications (1)

Publication Number Publication Date
HK196796A true HK196796A (en) 1996-11-01

Family

ID=10593121

Family Applications (1)

Application Number Title Priority Date Filing Date
HK196796A HK196796A (en) 1986-02-15 1996-10-24 Use of aromatic diamines for the treatment of angina pectoris and diamines therefor

Country Status (11)

Country Link
US (1) US5494933A (de)
EP (1) EP0233762B1 (de)
JP (2) JP2543690B2 (de)
AU (1) AU6877987A (de)
DE (1) DE3781174T2 (de)
DK (1) DK75587A (de)
GB (1) GB8603765D0 (de)
HK (1) HK196796A (de)
NZ (1) NZ219267A (de)
PT (1) PT84294B (de)
ZA (1) ZA871062B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1205124B (it) * 1987-06-05 1989-03-15 Simens Soteta Italiana Medicin Composto attivo nella terapia carciovascolare
JP2699511B2 (ja) * 1988-01-29 1998-01-19 武田薬品工業株式会社 置換アミン類
IT1229214B (it) * 1989-03-31 1991-07-25 Alfa Wassermann S P A Contrada Processo per la sintesi della n metil 3,4 dimetossifeniletilamina
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
DK0555481T3 (da) * 1990-10-25 1997-07-28 Yamanouchi Pharma Co Ltd Tri(C1-C6-alkoxy)benzenderivat.
FR2691064B3 (fr) * 1992-05-14 1996-01-12 Beecham Laboratoires Nouveau medicament pour le traitement de l'arythmie.
FR2694557B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
FR2710059A1 (fr) * 1993-09-13 1995-03-24 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2710065B1 (fr) * 1993-09-13 1996-10-04 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2715652B1 (fr) * 1994-02-03 1996-03-22 Synthelabo Dérivés de N-[3-[(2,3-dihydro-1H-inden-2-yl)alkyl-amino]propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide leur préparation et leur application en thérapeutique.
TW281667B (de) * 1994-02-03 1996-07-21 Synthelabo
WO1996027595A1 (en) * 1995-03-08 1996-09-12 Smithkline Beecham Laboratoires Pharmaceutiques Heterocyclycarboxamides and other compounds for the treatment of the cardiac arrhythmias
GB9513756D0 (en) * 1995-07-06 1995-09-06 Smithkline Beecham Plc Novel process & compounds
US20090022720A1 (en) * 2007-07-20 2009-01-22 Stephan Fischer Conjugate of an antibody against CD4 and antifusogenic peptides

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670374A (en) * 1952-05-17 1954-02-23 Searle & Co N-dialkylaminoalkyl aminobenzanilides and n-aralkylaminobenzamides and their salts
GB862467A (en) * 1958-03-14 1961-03-08 American Cyanamid Co N-substituted anilides and acid addition salts thereof
US2944081A (en) * 1958-03-14 1960-07-05 American Cyanamid Co Diphenyl alkylenediamines and methods of preparing the same
FR965M (de) * 1960-02-04 1961-11-27
US3049552A (en) * 1960-11-03 1962-08-14 Merck & Co Inc Furfuryl isocyanates
US3049562A (en) * 1961-03-09 1962-08-14 American Cyanamid Co 1-(aralkyl, lower alkylamino lower alkyl), 1-phenyl, 3, 3-dilower alkylureas
GB1004071A (en) * 1961-07-03 1965-09-08 Council Scient Ind Res Substituted ª‰-phenethylamines and a process for the production thereof
DE1170961B (de) * 1962-04-19 1964-05-27 Roehm & Haas Gmbh Verfahren zur Herstellung von N-(N'-Methyl-N'-ª‰-phenaethylamino-tert.-butyl)-propionaniliden
GB1050132A (de) * 1963-03-01
US3196172A (en) * 1963-05-20 1965-07-20 American Cyanamid Co Trifluoromethylphenylalkylenediamines
US3365453A (en) * 1963-10-28 1968-01-23 Sterling Drug Inc 1-phenyl-4-lower-alkyl-2-piperazinones
GB1232787A (de) * 1967-08-08 1971-05-19
US3528990A (en) * 1967-11-14 1970-09-15 Colgate Palmolive Co 1-aminoalkyl derivatives of 2,1-benzisothiazoline
US3789073A (en) * 1970-04-22 1974-01-29 Squibb & Sons Inc Adamantylalkylaminoalkyl benzamides
CH618571A4 (de) * 1970-05-16 1976-09-30
US4322434A (en) * 1979-05-04 1982-03-30 Schering Corporation N-Substituted-4-(polyfluoro-2-hydroxy-2-propyl)anilines and compounds related thereto
EP0072061B1 (de) * 1981-08-05 1985-05-15 FISONS plc Aminderivate, Verfahren zu deren Produktion und diese enthaltende pharmazeutische Zusammensetzungen
US4562201A (en) * 1982-07-26 1985-12-31 American Hospital Supply Corporation Aminomethyl benzanilides
DE3242344A1 (de) * 1982-11-16 1984-05-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue alkylendiaminoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
DE3428526A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminoalkohole, verfahren zu deren herstellung sowie diese verbindung enthaltende arzneimittel
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
JPH0328137A (ja) * 1989-06-23 1991-02-06 Nippon Sheet Glass Co Ltd 平坦な面を有するガラス容器成形方法

Also Published As

Publication number Publication date
DK75587A (da) 1987-08-16
EP0233762A2 (de) 1987-08-26
DE3781174D1 (de) 1992-09-24
GB8603765D0 (en) 1986-03-19
DE3781174T2 (de) 1993-02-11
PT84294A (en) 1987-03-01
JPS62240653A (ja) 1987-10-21
JP2663258B2 (ja) 1997-10-15
EP0233762A3 (en) 1989-05-10
PT84294B (pt) 1989-09-14
ZA871062B (en) 1988-10-26
US5494933A (en) 1996-02-27
EP0233762B1 (de) 1992-08-19
DK75587D0 (da) 1987-02-13
JPH08268983A (ja) 1996-10-15
AU6877987A (en) 1987-08-20
NZ219267A (en) 1990-11-27
JP2543690B2 (ja) 1996-10-16

Similar Documents

Publication Publication Date Title
GR1002240B (en) Agents for the prophgylaxis and therapy of retroviral infections
HK196796A (en) Use of aromatic diamines for the treatment of angina pectoris and diamines therefor
EP0254390A3 (en) Combination stretcher and stairchair
GB8621869D0 (en) Treatment
ZW18186A1 (en) Combination preparations for the treatment of malaria
GB8600624D0 (en) Sling
GB8501488D0 (en) Treatment
ZA879505B (en) Flyslag treatment
GB8706821D0 (en) Aromatic diamines
EP0185283A3 (en) Use of dihydropyridines for the treatment and prevention of arteriosclerosis
PH22377A (en) 5-aryl-2,4-diakyl-3h-1,2,4-triazole-3-thiones and their use as anti-depressant
ZA876845B (en) Pharmacologically active compounds and use
GB8617528D0 (en) Gas treatment
GB8715691D0 (en) Silylating aromatic imides
GB8617623D0 (en) Treatment
GB2182536B (en) The treatment of meat
ZA874979B (en) Pharmacologically active compounds and use
IL83657A0 (en) Processes and intermediates for the preparation of n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycycl-d-alanine
GB8615669D0 (en) Treatment
GB8630038D0 (en) Treatment of inorganic material
IE870383L (en) Treatment of angina
GB8829345D0 (en) Treatment of inorganic material
BG40988A1 (en) Means for prophylaxy and treatment of seboreic state
GB8619095D0 (en) Treatment
GB8608919D0 (en) Treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)